🇺🇸 FDA
Patent

US 9399666

Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices

granted A61KA61K38/00A61P

Quick answer

US patent 9399666 (Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P11/00, A61P13/00